Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Nerve block injection is a local anesthetic used during surgery to control pain and reduce or eliminate the use of opioids for acute postoperative pain.
Global Nerve Block Injection market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nerve Block Injection market research.
Key manufacturers engaged in the Nerve Block Injection industry include Pfizer, Pacira, Fresenius Kabi, Aspen Pharmacare, AstraZeneca, Eugia US, Aurobindo, Akorn and Somerset Pharma, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Nerve Block Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Nerve Block Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nerve Block Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Segment by Type
Segment by Application
Consumption by Region
The Nerve Block Injection report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index
1 Nerve Block Injection Market Overview
1.1 Product Overview and Scope of Nerve Block Injection
1.2 Nerve Block Injection Segment by Type
1.2.1 Global Nerve Block Injection Market Value Comparison by Type (2023-2029)
1.2.2 Esters Local Anesthetics
1.2.3 Amide Local Anesthetics
1.3 Nerve Block Injection Segment by Application
1.3.1 Global Nerve Block Injection Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Nerve Block Injection Market Size Estimates and Forecasts
1.4.1 Global Nerve Block Injection Revenue 2018-2029
1.4.2 Global Nerve Block Injection Sales 2018-2029
1.4.3 Global Nerve Block Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Nerve Block Injection Market Competition by Manufacturers
2.1 Global Nerve Block Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Nerve Block Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Nerve Block Injection Average Price by Manufacturers (2018-2023)
2.4 Global Nerve Block Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Nerve Block Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nerve Block Injection, Product Type & Application
2.7 Nerve Block Injection Market Competitive Situation and Trends
2.7.1 Nerve Block Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nerve Block Injection Players Market Share by Revenue
2.7.3 Global Nerve Block Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nerve Block Injection Retrospective Market Scenario by Region
3.1 Global Nerve Block Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Nerve Block Injection Global Nerve Block Injection Sales by Region: 2018-2029
3.2.1 Global Nerve Block Injection Sales by Region: 2018-2023
3.2.2 Global Nerve Block Injection Sales by Region: 2024-2029
3.3 Global Nerve Block Injection Global Nerve Block Injection Revenue by Region: 2018-2029
3.3.1 Global Nerve Block Injection Revenue by Region: 2018-2023
3.3.2 Global Nerve Block Injection Revenue by Region: 2024-2029
3.4 North America Nerve Block Injection Market Facts & Figures by Country
3.4.1 North America Nerve Block Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Nerve Block Injection Sales by Country (2018-2029)
3.4.3 North America Nerve Block Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nerve Block Injection Market Facts & Figures by Country
3.5.1 Europe Nerve Block Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Nerve Block Injection Sales by Country (2018-2029)
3.5.3 Europe Nerve Block Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nerve Block Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Nerve Block Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Nerve Block Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Nerve Block Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Nerve Block Injection Market Facts & Figures by Country
3.7.1 Latin America Nerve Block Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Nerve Block Injection Sales by Country (2018-2029)
3.7.3 Latin America Nerve Block Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Nerve Block Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Nerve Block Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Nerve Block Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Nerve Block Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nerve Block Injection Sales by Type (2018-2029)
4.1.1 Global Nerve Block Injection Sales by Type (2018-2023)
4.1.2 Global Nerve Block Injection Sales by Type (2024-2029)
4.1.3 Global Nerve Block Injection Sales Market Share by Type (2018-2029)
4.2 Global Nerve Block Injection Revenue by Type (2018-2029)
4.2.1 Global Nerve Block Injection Revenue by Type (2018-2023)
4.2.2 Global Nerve Block Injection Revenue by Type (2024-2029)
4.2.3 Global Nerve Block Injection Revenue Market Share by Type (2018-2029)
4.3 Global Nerve Block Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Nerve Block Injection Sales by Application (2018-2029)
5.1.1 Global Nerve Block Injection Sales by Application (2018-2023)
5.1.2 Global Nerve Block Injection Sales by Application (2024-2029)
5.1.3 Global Nerve Block Injection Sales Market Share by Application (2018-2029)
5.2 Global Nerve Block Injection Revenue by Application (2018-2029)
5.2.1 Global Nerve Block Injection Revenue by Application (2018-2023)
5.2.2 Global Nerve Block Injection Revenue by Application (2024-2029)
5.2.3 Global Nerve Block Injection Revenue Market Share by Application (2018-2029)
5.3 Global Nerve Block Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Nerve Block Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Nerve Block Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Pacira
6.2.1 Pacira Corporation Information
6.2.2 Pacira Description and Business Overview
6.2.3 Pacira Nerve Block Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Pacira Nerve Block Injection Product Portfolio
6.2.5 Pacira Recent Developments/Updates
6.3 Fresenius Kabi
6.3.1 Fresenius Kabi Corporation Information
6.3.2 Fresenius Kabi Description and Business Overview
6.3.3 Fresenius Kabi Nerve Block Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Fresenius Kabi Nerve Block Injection Product Portfolio
6.3.5 Fresenius Kabi Recent Developments/Updates
6.4 Aspen Pharmacare
6.4.1 Aspen Pharmacare Corporation Information
6.4.2 Aspen Pharmacare Description and Business Overview
6.4.3 Aspen Pharmacare Nerve Block Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Aspen Pharmacare Nerve Block Injection Product Portfolio
6.4.5 Aspen Pharmacare Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Nerve Block Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 AstraZeneca Nerve Block Injection Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Eugia US
6.6.1 Eugia US Corporation Information
6.6.2 Eugia US Description and Business Overview
6.6.3 Eugia US Nerve Block Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Eugia US Nerve Block Injection Product Portfolio
6.6.5 Eugia US Recent Developments/Updates
6.7 Aurobindo
6.6.1 Aurobindo Corporation Information
6.6.2 Aurobindo Description and Business Overview
6.6.3 Aurobindo Nerve Block Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Aurobindo Nerve Block Injection Product Portfolio
6.7.5 Aurobindo Recent Developments/Updates
6.8 Akorn
6.8.1 Akorn Corporation Information
6.8.2 Akorn Description and Business Overview
6.8.3 Akorn Nerve Block Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Akorn Nerve Block Injection Product Portfolio
6.8.5 Akorn Recent Developments/Updates
6.9 Somerset Pharma
6.9.1 Somerset Pharma Corporation Information
6.9.2 Somerset Pharma Description and Business Overview
6.9.3 Somerset Pharma Nerve Block Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Somerset Pharma Nerve Block Injection Product Portfolio
6.9.5 Somerset Pharma Recent Developments/Updates
6.10 Amphastar Pharmaceuticals
6.10.1 Amphastar Pharmaceuticals Corporation Information
6.10.2 Amphastar Pharmaceuticals Description and Business Overview
6.10.3 Amphastar Pharmaceuticals Nerve Block Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Amphastar Pharmaceuticals Nerve Block Injection Product Portfolio
6.10.5 Amphastar Pharmaceuticals Recent Developments/Updates
6.11 Hikma
6.11.1 Hikma Corporation Information
6.11.2 Hikma Nerve Block Injection Description and Business Overview
6.11.3 Hikma Nerve Block Injection Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Hikma Nerve Block Injection Product Portfolio
6.11.5 Hikma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nerve Block Injection Industry Chain Analysis
7.2 Nerve Block Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nerve Block Injection Production Mode & Process
7.4 Nerve Block Injection Sales and Marketing
7.4.1 Nerve Block Injection Sales Channels
7.4.2 Nerve Block Injection Distributors
7.5 Nerve Block Injection Customers
8 Nerve Block Injection Market Dynamics
8.1 Nerve Block Injection Industry Trends
8.2 Nerve Block Injection Market Drivers
8.3 Nerve Block Injection Market Challenges
8.4 Nerve Block Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research